Patients with type 2 diabetes have a greater risk for death after development of heart failure compared with other cardiovascular or renal diagnoses.
Sugar-sweetened beverage tax designs are expected to generate substantial health gains and cost savings.
Characteristics that are independently associated with hospitalization for COVID-19 include older age, black race, and having diabetes mellitus.
Insulin resistance is one factor mediating part of the association between race and poor prognosis in breast cancer.
Adopting the 2019 Endocrine Society guidelines for diabetes screening would substantially increase the number of older adults classified as having T2D but would likely offer limited benefits.
A clinical perspective article details the recommended approach to manage diabetic ketoacidosis in patients with diabetes during the COVID-19 pandemic.
Researchers developed a clinical tool to identify patients at risk for persistent abnormal glucose levels during hospitalization.
The FDA has approved Gimoti™ (metoclopramide; Evoke Pharma) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Metabolic traits associated with adult diabetes risk may be detectable by age 8 years.
Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.